In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia
Diogo Gonçalves(Pfizer (France)), Christian Czech(Pfizer (United States))
Cited by 31
Related Papers
Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
|EMBO Reports|2006|1k
Patients with autism spectrum disorders display reproducible functional connectivity alterations
|Science Translational Medicine|2019|180